MassARRAY^® SARS-CoV-2 Panel

High Throughput, Low Cost SARS-CoV-2 Detection

Increasing laboratory efficiency with scalable solutions

United States: For in vitro diagnostic use – FDA Emergency Use Authorization (EUA).
Europe: CE-IVD marked and intended for in vitro diagnostic use in Europe.

The MassARRAY^® SARS-CoV-2 Panel from Agena Bioscience^® enables laboratories to meet the demands of the COVID-19 pandemic with a high-throughput and low-cost assay for the detection of the novel coronavirus, SARS-CoV-2.

The MassARRAY SARS-CoV-2 Panel is now available, with:

• ACCURATE DETECTION: Five SARS-CoV-2 assays multiplexed into a single reaction, targeting the nucleocapsid (N) gene and ORF1ab region.
• SCALABLE THROUGHPUT: Process up to thousands of samples per day with a single instrument.
• LOW COST: Low-cost reagents and automated results reporting saves lab resources.
• RELIABLE SUPPLY: Overcome instrument and reagent shortages with a reliable supply.

Panel Resources